Recent advances in cancer care continue to offer optimism for patients. Investigators are intensely exploring novel approaches, including immune therapies , targeted agents, and personalized medicine . A significant study published this week demonstrates the efficacy of a new drug in treating late-stage NSCLC. Furthermore, continued investigations